Spots Global Cancer Trial Database for A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Official Title: A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
Study ID: NCT04552977
Conditions
Study Description
Brief Summary: This is a one arm, open, single center phase II study. The main purpose of this study was to evaluate the efficacy and safety of fluzoparil combined with temozolomide in patients with recurrent glioblastoma.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Name: Jinming Yu, Ph.D, M.D
Affiliation: Shandong Cancer Hospital and Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
